Le Tong

635 total citations
27 papers, 368 citations indexed

About

Le Tong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Le Tong has authored 27 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Le Tong's work include Immune Cell Function and Interaction (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Cancer Cells and Metastasis (4 papers). Le Tong is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Cancer Cells and Metastasis (4 papers). Le Tong collaborates with scholars based in China, Sweden and Singapore. Le Tong's co-authors include Andreas Lundqvist, Lorenzo Galluzzi, Carlos Jiménez‐Cortegana, Stina L. Wickström, Chao Wu, Xifan Mei, He Tian, Qian Wu, Shiyong Neo and Haishuang Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Oncology and International Journal of Pharmaceutics.

In The Last Decade

Le Tong

23 papers receiving 363 citations

Peers

Le Tong
Jianquan Yang United States
Ani Solanki United States
Rakesh Trivedi United States
Shahana S. Mahajan United States
Aaron Dolor United States
Geoffrey Kuesters United States
Le Tong
Citations per year, relative to Le Tong Le Tong (= 1×) peers Siyuan Hou

Countries citing papers authored by Le Tong

Since Specialization
Citations

This map shows the geographic impact of Le Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Tong more than expected).

Fields of papers citing papers by Le Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Tong. The network helps show where Le Tong may publish in the future.

Co-authorship network of co-authors of Le Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Le Tong. A scholar is included among the top collaborators of Le Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Tong. Le Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, Le, Weiyingqi Cui, Yaxuan Liu, et al.. (2025). VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function. Cancer Immunology Immunotherapy. 74(9). 278–278.
2.
Tong, Le, Veronika Kremer, Shiyong Neo, et al.. (2025). Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patients. OncoImmunology. 14(1). 2481109–2481109. 1 indexed citations
3.
Cheng, Jiahui, Le Li, Le Tong, et al.. (2025). Synthetic biology-inspired development of live attenuated influenza vaccines. npj Vaccines. 10(1). 204–204. 2 indexed citations
4.
Koning, Marije, Sébastien J. Dumas, Elda Meta, et al.. (2025). Single cell transcriptomics of human kidney organoid endothelium reveals vessel growth processes and arterial maturation upon transplantation. npj Regenerative Medicine. 10(1). 32–32. 1 indexed citations
6.
Neo, Shiyong, Mariana M.S. Oliveira, Le Tong, et al.. (2024). Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease. Journal of Experimental & Clinical Cancer Research. 43(1). 13–13. 9 indexed citations
7.
Fonseca, Pedro, Weiyingqi Cui, Le Tong, et al.. (2024). A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells. Journal of Experimental & Clinical Cancer Research. 43(1). 107–107.
8.
Tong, Le, Weiyingqi Cui, Boya Zhang, et al.. (2024). Patient-derived organoids in precision cancer medicine. Med. 5(11). 1351–1377. 38 indexed citations
9.
Chen, Ziqing, Le Tong, Shiyong Neo, et al.. (2023). CD25 bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression. OncoImmunology. 12(1). 2175517–2175517. 8 indexed citations
10.
Cui, Weiyingqi, Pedro Fonseca, Yumeng Zhang, et al.. (2023). Deciphering the Role of p60AmotL2 in Epithelial Extrusion and Cell Detachment. Cells. 12(17). 2158–2158. 1 indexed citations
11.
Wen, Shan, Qian Wu, Le Tong, et al.. (2023). The apoptotic body membrane derived from T lymphocytes is used as an enzyme carrier to treat ischemic stroke. Materials & Design. 234. 112305–112305. 3 indexed citations
12.
Chen, Xinsong, Emmanouil G. Sifakis, Stephanie Robertson, et al.. (2022). 1668P Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction. Annals of Oncology. 33. S1306–S1306. 1 indexed citations
13.
Tong, Le, et al.. (2022). A self-microemulsion enhances oral absorption of docetaxel by inhibiting P-glycoprotein and CYP metabolism. Drug Delivery and Translational Research. 13(4). 983–993. 10 indexed citations
14.
Tong, Le, et al.. (2022). NK cells and solid tumors: therapeutic potential and persisting obstacles. Molecular Cancer. 21(1). 206–206. 108 indexed citations
15.
Du, Qiqiao, Jieyu Wu, Carina Fischer, et al.. (2022). Generation of mega brown adipose tissue in adults by controlling brown adipocyte differentiation in vivo. Proceedings of the National Academy of Sciences. 119(40). e2203307119–e2203307119. 4 indexed citations
16.
Neo, Shiyong, Le Tong, Dongmei Tong, et al.. (2022). Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cells. Journal for ImmunoTherapy of Cancer. 10(10). e005308–e005308. 11 indexed citations
17.
Wu, Qian, et al.. (2022). Chitosan-modified hollow manganese dioxide nanoparticles loaded with resveratrol for the treatment of spinal cord injury. Drug Delivery. 29(1). 2498–2512. 29 indexed citations
18.
Wu, Qian, Le Tong, Wenwen Shen, et al.. (2022). Herceptin-functionalized SK-BR-3 cell membrane-wrapped paclitaxel nanocrystals for enhancing the targeted therapy effect of HER2-positive breast cancer. Materials & Design. 219. 110818–110818. 12 indexed citations
19.
Chen, Ziqing, Ying Yang, Shiyong Neo, et al.. (2021). Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25 + /CD54 + NK cells. EMBO Reports. 22(3). e51329–e51329. 8 indexed citations
20.
Shi, Ningning, Qi Yang, Haoran Zhang, et al.. (2021). Restoration of dystrophin expression in mice by suppressing a nonsense mutation through the incorporation of unnatural amino acids. Nature Biomedical Engineering. 6(2). 195–206. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026